QDEL Stock Surge: Diagnostic Unit Sale Hopes or Debt Reduction Revaluation?
Key Takeaways QuidelOrtho (QDEL) surged after reports that the company may sell its Point-of-Care testing business for approximately $1.5 billion. The market reaction is not mainly about a sudden improvement in Q1 results. It is about whether a potential asset sale could reduce debt and reshape the company’s valuation. The reported sale process is meaningful, … Read more